Codexis, Inc. is a pioneering biotechnology firm headquartered in Redwood City, California, specializing in the discovery, development, and commercialization of innovative biocatalysts. The company's proprietary enzyme technology enables more sustainable and efficient manufacturing processes across various industries, including pharmaceuticals, chemicals, and food. With a strong emphasis on research and development, Codexis leverages advanced protein engineering techniques to enhance enzyme performance, positioning itself as a leader in biocatalyst applications. As sustainability becomes increasingly vital in industrial processes, Codexis presents a compelling investment opportunity for those interested in the transformative potential of biotechnology.